| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0f9533575751b2321d1ec25271480dc9 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J43-003
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J71-0047
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D237-32 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D237-32 |
| filingDate |
2020-11-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_62788b410beeddfe9e6275b0137bc520
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b3898e994fecb4195502928b583001f7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9a90f5017f6993807bf9e988a5bd3281
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4416a1e74b2990ff2252dfba24b7aef3 |
| publicationDate |
2021-07-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2021214316-A1 |
| titleOfInvention |
Anti-cancer nuclear hormone receptor-targeting compounds |
| abstract |
The disclosure relates to anti-cancer compounds derived from nuclear steroid receptor binders, to products containing the same, as well as to methods of their use and preparation. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114276406-A |
| priorityDate |
2019-11-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |